Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Fuji
Express Scripts
Colorcon
Argus Health
Covington
Fish and Richardson
Citi
Cerilliant

Generated: October 19, 2018

DrugPatentWatch Database Preview

PARSIDOL Drug Profile

« Back to Dashboard

When do Parsidol patents expire, and when can generic versions of Parsidol launch?

Parsidol is a drug marketed by Parke Davis and is included in one NDA.

The generic ingredient in PARSIDOL is ethopropazine hydrochloride. There is one drug master file entry for this compound. Additional details are available on the ethopropazine hydrochloride profile page.

Summary for PARSIDOL
Drug patent expirations by year for PARSIDOL
Synonyms for PARSIDOL
10-(2-(Diethylamino)propyl)-phenothiazin Hydrochloride
10-(2-(Diethylamino)propyl)phenothiazine monohydrochloride
10-[2-(Diethylamino)propyl]phenothiazine hydrochloride
10-Phenothiazineethylamine, N,N-diethyl-alpha-methyl-, hydrochloride
1094-08-2
10H-Phenothiazine-10-ethanamine, N,N-diethyl-alpha-methyl-, monohydrochloride
10H-Phenothiazine-10-ethanamine,N-diethyl-.alpha.-methyl-, monohydrochloride
10H-Phenothiazine-10-ethanamine,N,N-diethyl-a-methyl-,hydrochloride(1:1)
42957-54-0
AC1L3VBR
AC1Q3FBW
AKOS015901042
API0008593
C19H24N2S.HCl
CAS-1094-08-2
CCG-40202
CHEBI:31568
CHEMBL1200970
D01118
Dibutil
Dibutil hydrochloride
diethyl(1-methyl-2-phenothiazin-10-ylethyl)amine, chloride
DIETHYL[1-(10H-PHENOTHIAZIN-10-YL)PROPAN-2-YL]AMINE HYDROCHLORIDE
DSSTox_CID_25347
DSSTox_GSID_45347
DSSTox_RID_80815
DTXSID4045347
EINECS 214-134-4
EINECS 256-019-1
Ethopropazine HCl
Ethopropazine hydrochloride
Ethopropazine hydrochloride [USP]
Ethopropazine hydrochloride, >=98% (HPLC), powder
ethopropazine monohydrochloride
FT-0625740
HMS1570H21
HMS1920O04
I14-15990
Isothazine hydrochloride
l-10-(2-Diethylaminopropyl)phenothiazine hydrochloride
LP00873
LS-105454
Lysivane
Lysivane hydrochloride
MCULE-2860573503
MFCD00012653
N,N-diethyl-1-(10H-phenothiazin-10-yl)propan-2-amine hydrochloride
N,N-diethyl-1-phenothiazin-10-ylpropan-2-amine hydrochloride
N,N-diethyl-1-phenothiazin-10-ylpropan-2-amine;hydrochloride
N,N-diethyl-alpha-methyl-10H-phenothiazine-10-ethylamine hydrochloride
N,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethylamine monohydrochloride
NCGC00016562-01
NCGC00094678-01
NCGC00094678-02
NCGC00178860-06
NCGC00261558-01
NSC 169467
NSC 64074
NSC-169467
NSC-64074
NSC-757029
NSC169467
NSC64074
NSC757029
Pardisol
Parfezin
Parphezein
Parphezin
Parsidol (TN)
Parsidol (VAN)
Parsidol hydrochloride
Parsidol monohydrochloride
Pharmakon1600-01500293
Phenothiazine, 10-(2-(diethylamino)propyl)-, monohydrochloride
PL006821
Prestwick_195
Profenamine HCl
Profenamine hibenzate
Profenamine hydrochloride
Profenamine hydrochloride (JAN)
Profenamine monohydrochloride
Prophenamine HCl
SBB057672
SCHEMBL123703
SPECTRUM1500293
SR-05000001626
SR-05000001626-2
ST51006789
Tox21_110496
Tox21_110496_1
Tox21_500873
VXPCQISYVPFYRK-UHFFFAOYSA-N

US Patents and Regulatory Information for PARSIDOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parke Davis PARSIDOL ethopropazine hydrochloride TABLET;ORAL 009078-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Parke Davis PARSIDOL ethopropazine hydrochloride TABLET;ORAL 009078-006 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Parke Davis PARSIDOL ethopropazine hydrochloride TABLET;ORAL 009078-008 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Fuji
Express Scripts
Colorcon
Argus Health
Covington
Fish and Richardson
Citi
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.